Fortune Brands Innovations, Inc.: Form 10-K for the period ended Dec 31, 2020
Filed with the SEC on Feb 24, 2021 and accepted by EDGAR at Feb 24, 2021, 16:35 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2020-10-01 to 2020-12-31 | $1.66bn | us-gaap:Revenues |
| Revenue | 12 months2020-01-01 to 2020-12-31 | $6.09bn | us-gaap:Revenues |
| Cost of revenue | 12 months2020-01-01 to 2020-12-31 | $3.93bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2020-10-01 to 2020-12-31 | $607.7m | us-gaap:GrossProfit |
| Gross profit | 12 months2020-01-01 to 2020-12-31 | $2.16bn | us-gaap:GrossProfit |
| Selling, general and administrative | 12 months2020-01-01 to 2020-12-31 | $1.28bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2020-10-01 to 2020-12-31 | $233.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 12 months2020-01-01 to 2020-12-31 | $801.4m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2020-01-01 to 2020-12-31 | $83.9m | us-gaap:InterestExpense |
| Income tax | 12 months2020-01-01 to 2020-12-31 | $168.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2020-10-01 to 2020-12-31 | $163.6m | us-gaap:ProfitLoss |
| Net income | 12 months2020-01-01 to 2020-12-31 | $553.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2020-10-01 to 2020-12-31 | $1.16 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months2020-01-01 to 2020-12-31 | $3.94 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2020-10-01 to 2020-12-31 | $1.18 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months2020-01-01 to 2020-12-31 | $3.99 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2020-01-01 to 2020-12-31 | 140,200,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2020-01-01 to 2020-12-31 | $825.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2020-01-01 to 2020-12-31 | $150.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2020-01-01 to 2020-12-31 | $133.3m | us-gaap:PaymentsOfDividends |
| Share repurchases | 12 months2020-01-01 to 2020-12-31 | $187.6m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2020-12-31 | $419.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2020-12-31 | $2.21bn | us-gaap:AssetsCurrent |
| Total assets | At period end2020-12-31 | $7.36bn | us-gaap:Assets |
| Current liabilities | At period end2020-12-31 | $1.35bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2020-12-31 | $4.58bn | us-gaap:Liabilities |
| Long-term debt | At period end2020-12-31 | $2.57bn | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2020-12-31 | $2.78bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001564590-21-008129. Last ingested by Listed: Nov 10, 2026, 02:09 ET. Listed shows no prices and gives no investment advice.